Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile.
Saved in:
| Title: | Janus kinase and calcineurin‐inhibitor combination in anti‐MDA5 dermatomyositis: No significant survival benefit but reassuring safety profile. |
|---|---|
| Authors: | Pagis, Valentine1 (AUTHOR) valentine.pagis@aphp.fr, Astouati, Quentin2 (AUTHOR), Pacoureau, Lucas3 (AUTHOR), Nguyen, Yann4 (AUTHOR), Bay, Pierre5,6 (AUTHOR), Roux, Antoine7 (AUTHOR), Gallay, Laure8 (AUTHOR), Cottin, Vincent9 (AUTHOR), Terrier, Benjamin10 (AUTHOR), Meyer, Alain11 (AUTHOR), Cerf, Charles12 (AUTHOR), Neuville, Mathilde12 (AUTHOR), Hervier, Baptiste13 (AUTHOR), Renaud, Arthur14 (AUTHOR), Suzon, Benoit15 (AUTHOR), Schleinitz, Nicolas16 (AUTHOR), Papo, Thomas17 (AUTHOR), Priou, Pascaline18 (AUTHOR), Mekinian, Arsène19 (AUTHOR), Ullmer, Audrey20 (AUTHOR) |
| Source: | Journal of Internal Medicine. Feb2026, Vol. 299 Issue 2, p228-240. 13p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
